Oct 24, 2023 · 49m · my-first-million

If I Could Start Over Again, This Is What I’d Do To Get Rich - Scott Galloway

Scott Galloway · 29m spoken Sam Parr · 9m spoken Shaan Puri · 4m spoken
0:00 / 0:00
▶ Watch on YouTube →

gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions

Serial entrepreneur and NYU professor Scott Galloway shares actionable business playbooks for young founders, analyzes massive market disruptions across healthcare and GLP-1 drugs, and candidly explores the psychological realities of wealth and public fame.

How this conversation actually went

Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. The hosts hold 32.2% of the talking time here. How this is scored →

The hosts as informed peer 2.9 Guest teaching 4.8 Guest disagreement 2.7 The hosts pushing back 2.3
05100:0015:0030:0045:001:30–5:20 · The hosts as informed peer 1/10 Opening Compliments and Persona Comparison Sam opens the show with flattering comparisons and praise for Scott's personal brand and writing style. Scott graciously accepts the compliments and shares early career anecdotes on developing resilience through failure.5:20–8:35 · The hosts as informed peer 2/10 Financial Anxiety and the Landmark L2 Exit Shaan asks Scott about reaching financial security, prompting Scott to explain his persistent financial anxiety and the mechanics of the $158M L2 acquisition. Scott educates the hosts on how compounding capital generates greater wealth than operational businesses.8:39–10:54 · The hosts as informed peer 3/10 Commercial Break: HubSpot CRM Platform Following a brief commercial break, Scott turns the spotlight back onto Sam, demanding to hear his exact exit numbers. Sam admits to walking away with $20M while still battling financial neurosis.10:55–14:31 · The hosts as informed peer 3/10 Wealth Defense, Living Below Means, and Neurosis Shaan pushes Scott on whether feeling broke with over a hundred million dollars is genuine neurosis or calculated virtue-signaling. Scott defends his anxiety as an authentic driver that enforces strict capital preservation discipline.14:32–20:01 · The hosts as informed peer 3/10 The Stabilizing Power of Recurring Cash Flow Scott lays out detailed strategic playbooks for 25-year-olds, contrasting seller-financed acquisitions of boomer service businesses for non-credentialed youth against corporate platform careers for elite graduates.20:01–22:54 · The hosts as informed peer 4/10 Disrupting Healthcare Through Artificial Intelligence Sam pushes back against Scott's recommendation of healthcare AI startups by highlighting regulatory capture and insurance friction. Scott counters forcefully, framing US healthcare as an unsustainable multi-trillion-dollar carcass ripe for disruption.22:54–26:23 · The hosts as informed peer 3/10 The Revolutionary Impact of GLP-1 Weight Loss Drugs Scott argues that GLP-1 weight loss drugs will have a larger economic impact than generative AI by scaffolding human evolutionary biology against hyper-palatable industrial foods.26:24–31:39 · The hosts as informed peer 5/10 First-Hand GLP-1 Experiences and Treatment Dynamics Sam shares specific domain knowledge from personal semaglutide usage regarding titration schedules, costs, and muscle loss side effects. Scott expands the discussion into broader macroeconomic impacts on hospital networks and pharmaceutical stocks.31:39–35:19 · The hosts as informed peer 2/10 Pharmacy Realities, Accutane, and Self-Deprecation After bantering about public pharmacy announcements, Scott shares a personal story about how Accutane cured his severe adolescent acne and transformed his confidence. The hosts lightly rib Scott about his humblebrag problems.35:19–39:41 · The hosts as informed peer 4/10 The Inverse Galloway Index and Online Retaliation Sam cites the Inverse Galloway Index showing tech companies Scott bet against beating the market by 61%. Scott mounts a spirited defense, calling out cherry-picked data windows and online bot campaigns funded by crypto and VC detractors.39:41–42:56 · The hosts as informed peer 3/10 Information Warfare and Digital Disinformation Sam directly challenges Scott on whether foreign bot farms are targeting him or if he is overestimating his significance to geopolitical actors. Scott insists that high-profile commentators are obvious targets for asymmetric disinformation campaigns.42:57–47:56 · The hosts as informed peer 2/10 Public Fame vs. The Ideal of Being Rich and Anonymous Scott reflects on the validation of public notoriety versus the ideal of remaining rich and anonymous. He then reveals the rigorous analytical preparation and humor design behind his six-figure keynote speaking engagements.1:30–5:20 · Guest teaching 2/10 Opening Compliments and Persona Comparison Sam opens the show with flattering comparisons and praise for Scott's personal brand and writing style. Scott graciously accepts the compliments and shares early career anecdotes on developing resilience through failure.5:20–8:35 · Guest teaching 5/10 Financial Anxiety and the Landmark L2 Exit Shaan asks Scott about reaching financial security, prompting Scott to explain his persistent financial anxiety and the mechanics of the $158M L2 acquisition. Scott educates the hosts on how compounding capital generates greater wealth than operational businesses.8:39–10:54 · Guest teaching 3/10 Commercial Break: HubSpot CRM Platform Following a brief commercial break, Scott turns the spotlight back onto Sam, demanding to hear his exact exit numbers. Sam admits to walking away with $20M while still battling financial neurosis.10:55–14:31 · Guest teaching 6/10 Wealth Defense, Living Below Means, and Neurosis Shaan pushes Scott on whether feeling broke with over a hundred million dollars is genuine neurosis or calculated virtue-signaling. Scott defends his anxiety as an authentic driver that enforces strict capital preservation discipline.14:32–20:01 · Guest teaching 7/10 The Stabilizing Power of Recurring Cash Flow Scott lays out detailed strategic playbooks for 25-year-olds, contrasting seller-financed acquisitions of boomer service businesses for non-credentialed youth against corporate platform careers for elite graduates.20:01–22:54 · Guest teaching 6/10 Disrupting Healthcare Through Artificial Intelligence Sam pushes back against Scott's recommendation of healthcare AI startups by highlighting regulatory capture and insurance friction. Scott counters forcefully, framing US healthcare as an unsustainable multi-trillion-dollar carcass ripe for disruption.22:54–26:23 · Guest teaching 7/10 The Revolutionary Impact of GLP-1 Weight Loss Drugs Scott argues that GLP-1 weight loss drugs will have a larger economic impact than generative AI by scaffolding human evolutionary biology against hyper-palatable industrial foods.26:24–31:39 · Guest teaching 5/10 First-Hand GLP-1 Experiences and Treatment Dynamics Sam shares specific domain knowledge from personal semaglutide usage regarding titration schedules, costs, and muscle loss side effects. Scott expands the discussion into broader macroeconomic impacts on hospital networks and pharmaceutical stocks.31:39–35:19 · Guest teaching 3/10 Pharmacy Realities, Accutane, and Self-Deprecation After bantering about public pharmacy announcements, Scott shares a personal story about how Accutane cured his severe adolescent acne and transformed his confidence. The hosts lightly rib Scott about his humblebrag problems.35:19–39:41 · Guest teaching 5/10 The Inverse Galloway Index and Online Retaliation Sam cites the Inverse Galloway Index showing tech companies Scott bet against beating the market by 61%. Scott mounts a spirited defense, calling out cherry-picked data windows and online bot campaigns funded by crypto and VC detractors.39:41–42:56 · Guest teaching 4/10 Information Warfare and Digital Disinformation Sam directly challenges Scott on whether foreign bot farms are targeting him or if he is overestimating his significance to geopolitical actors. Scott insists that high-profile commentators are obvious targets for asymmetric disinformation campaigns.42:57–47:56 · Guest teaching 5/10 Public Fame vs. The Ideal of Being Rich and Anonymous Scott reflects on the validation of public notoriety versus the ideal of remaining rich and anonymous. He then reveals the rigorous analytical preparation and humor design behind his six-figure keynote speaking engagements.1:30–5:20 · Guest disagreement 1/10 Opening Compliments and Persona Comparison Sam opens the show with flattering comparisons and praise for Scott's personal brand and writing style. Scott graciously accepts the compliments and shares early career anecdotes on developing resilience through failure.5:20–8:35 · Guest disagreement 1/10 Financial Anxiety and the Landmark L2 Exit Shaan asks Scott about reaching financial security, prompting Scott to explain his persistent financial anxiety and the mechanics of the $158M L2 acquisition. Scott educates the hosts on how compounding capital generates greater wealth than operational businesses.8:39–10:54 · Guest disagreement 2/10 Commercial Break: HubSpot CRM Platform Following a brief commercial break, Scott turns the spotlight back onto Sam, demanding to hear his exact exit numbers. Sam admits to walking away with $20M while still battling financial neurosis.10:55–14:31 · Guest disagreement 3/10 Wealth Defense, Living Below Means, and Neurosis Shaan pushes Scott on whether feeling broke with over a hundred million dollars is genuine neurosis or calculated virtue-signaling. Scott defends his anxiety as an authentic driver that enforces strict capital preservation discipline.14:32–20:01 · Guest disagreement 2/10 The Stabilizing Power of Recurring Cash Flow Scott lays out detailed strategic playbooks for 25-year-olds, contrasting seller-financed acquisitions of boomer service businesses for non-credentialed youth against corporate platform careers for elite graduates.20:01–22:54 · Guest disagreement 4/10 Disrupting Healthcare Through Artificial Intelligence Sam pushes back against Scott's recommendation of healthcare AI startups by highlighting regulatory capture and insurance friction. Scott counters forcefully, framing US healthcare as an unsustainable multi-trillion-dollar carcass ripe for disruption.22:54–26:23 · Guest disagreement 3/10 The Revolutionary Impact of GLP-1 Weight Loss Drugs Scott argues that GLP-1 weight loss drugs will have a larger economic impact than generative AI by scaffolding human evolutionary biology against hyper-palatable industrial foods.26:24–31:39 · Guest disagreement 2/10 First-Hand GLP-1 Experiences and Treatment Dynamics Sam shares specific domain knowledge from personal semaglutide usage regarding titration schedules, costs, and muscle loss side effects. Scott expands the discussion into broader macroeconomic impacts on hospital networks and pharmaceutical stocks.31:39–35:19 · Guest disagreement 1/10 Pharmacy Realities, Accutane, and Self-Deprecation After bantering about public pharmacy announcements, Scott shares a personal story about how Accutane cured his severe adolescent acne and transformed his confidence. The hosts lightly rib Scott about his humblebrag problems.35:19–39:41 · Guest disagreement 6/10 The Inverse Galloway Index and Online Retaliation Sam cites the Inverse Galloway Index showing tech companies Scott bet against beating the market by 61%. Scott mounts a spirited defense, calling out cherry-picked data windows and online bot campaigns funded by crypto and VC detractors.39:41–42:56 · Guest disagreement 6/10 Information Warfare and Digital Disinformation Sam directly challenges Scott on whether foreign bot farms are targeting him or if he is overestimating his significance to geopolitical actors. Scott insists that high-profile commentators are obvious targets for asymmetric disinformation campaigns.42:57–47:56 · Guest disagreement 1/10 Public Fame vs. The Ideal of Being Rich and Anonymous Scott reflects on the validation of public notoriety versus the ideal of remaining rich and anonymous. He then reveals the rigorous analytical preparation and humor design behind his six-figure keynote speaking engagements.1:30–5:20 · The hosts pushing back 0/10 Opening Compliments and Persona Comparison Sam opens the show with flattering comparisons and praise for Scott's personal brand and writing style. Scott graciously accepts the compliments and shares early career anecdotes on developing resilience through failure.5:20–8:35 · The hosts pushing back 1/10 Financial Anxiety and the Landmark L2 Exit Shaan asks Scott about reaching financial security, prompting Scott to explain his persistent financial anxiety and the mechanics of the $158M L2 acquisition. Scott educates the hosts on how compounding capital generates greater wealth than operational businesses.8:39–10:54 · The hosts pushing back 1/10 Commercial Break: HubSpot CRM Platform Following a brief commercial break, Scott turns the spotlight back onto Sam, demanding to hear his exact exit numbers. Sam admits to walking away with $20M while still battling financial neurosis.10:55–14:31 · The hosts pushing back 4/10 Wealth Defense, Living Below Means, and Neurosis Shaan pushes Scott on whether feeling broke with over a hundred million dollars is genuine neurosis or calculated virtue-signaling. Scott defends his anxiety as an authentic driver that enforces strict capital preservation discipline.14:32–20:01 · The hosts pushing back 1/10 The Stabilizing Power of Recurring Cash Flow Scott lays out detailed strategic playbooks for 25-year-olds, contrasting seller-financed acquisitions of boomer service businesses for non-credentialed youth against corporate platform careers for elite graduates.20:01–22:54 · The hosts pushing back 5/10 Disrupting Healthcare Through Artificial Intelligence Sam pushes back against Scott's recommendation of healthcare AI startups by highlighting regulatory capture and insurance friction. Scott counters forcefully, framing US healthcare as an unsustainable multi-trillion-dollar carcass ripe for disruption.22:54–26:23 · The hosts pushing back 1/10 The Revolutionary Impact of GLP-1 Weight Loss Drugs Scott argues that GLP-1 weight loss drugs will have a larger economic impact than generative AI by scaffolding human evolutionary biology against hyper-palatable industrial foods.26:24–31:39 · The hosts pushing back 2/10 First-Hand GLP-1 Experiences and Treatment Dynamics Sam shares specific domain knowledge from personal semaglutide usage regarding titration schedules, costs, and muscle loss side effects. Scott expands the discussion into broader macroeconomic impacts on hospital networks and pharmaceutical stocks.31:39–35:19 · The hosts pushing back 2/10 Pharmacy Realities, Accutane, and Self-Deprecation After bantering about public pharmacy announcements, Scott shares a personal story about how Accutane cured his severe adolescent acne and transformed his confidence. The hosts lightly rib Scott about his humblebrag problems.35:19–39:41 · The hosts pushing back 4/10 The Inverse Galloway Index and Online Retaliation Sam cites the Inverse Galloway Index showing tech companies Scott bet against beating the market by 61%. Scott mounts a spirited defense, calling out cherry-picked data windows and online bot campaigns funded by crypto and VC detractors.39:41–42:56 · The hosts pushing back 6/10 Information Warfare and Digital Disinformation Sam directly challenges Scott on whether foreign bot farms are targeting him or if he is overestimating his significance to geopolitical actors. Scott insists that high-profile commentators are obvious targets for asymmetric disinformation campaigns.42:57–47:56 · The hosts pushing back 1/10 Public Fame vs. The Ideal of Being Rich and Anonymous Scott reflects on the validation of public notoriety versus the ideal of remaining rich and anonymous. He then reveals the rigorous analytical preparation and humor design behind his six-figure keynote speaking engagements.

speaking balance: gold is the hosts, purple is the guest (3 minute bins)

0:00 · the hosts 89.6% · guest 10.4%0:00 · the hosts 89.6% · guest 10.4%3:00 · the hosts 18.1% · guest 81.9%3:00 · the hosts 18.1% · guest 81.9%6:00 · the hosts 5.9% · guest 94.1%6:00 · the hosts 5.9% · guest 94.1%9:00 · the hosts 78.8% · guest 21.2%9:00 · the hosts 78.8% · guest 21.2%12:00 · the hosts 19.3% · guest 80.7%12:00 · the hosts 19.3% · guest 80.7%15:00 · the hosts 43.1% · guest 56.9%15:00 · the hosts 43.1% · guest 56.9%18:00 · the hosts 2.8% · guest 97.2%18:00 · the hosts 2.8% · guest 97.2%21:00 · the hosts 38.2% · guest 61.8%21:00 · the hosts 38.2% · guest 61.8%24:00 · the hosts 16.6% · guest 83.4%24:00 · the hosts 16.6% · guest 83.4%27:00 · the hosts 44.9% · guest 55.1%27:00 · the hosts 44.9% · guest 55.1%30:00 · the hosts 31.8% · guest 68.2%30:00 · the hosts 31.8% · guest 68.2%33:00 · the hosts 24% · guest 76%33:00 · the hosts 24% · guest 76%36:00 · the hosts 17.3% · guest 82.7%36:00 · the hosts 17.3% · guest 82.7%39:00 · the hosts 12.1% · guest 87.9%39:00 · the hosts 12.1% · guest 87.9%42:00 · the hosts 25.3% · guest 74.7%42:00 · the hosts 25.3% · guest 74.7%45:00 · the hosts 32.8% · guest 67.2%45:00 · the hosts 32.8% · guest 67.2%48:00 · the hosts 92.4% · guest 7.6%48:00 · the hosts 92.4% · guest 7.6%
Sharpest disagreement ▶ 41:31 Scott vigorously defends information warfare thesis

Scott forcefully rejects Sam's skeptical framing about his personal relevance to state actors, arguing with heightened intensity that foreign adversaries would be foolish not to target prominent media commentators.

Hardest push from the hosts ▶ 40:31 Sam challenges guest's paranoia and stature

Sam refuses Scott's narrative that online harassment is state-sponsored intelligence warfare, demanding empirical proof and openly questioning whether Scott is a big enough fish for foreign intelligence.

Biggest teaching moment ▶ 23:44 Scott educates hosts on GLP-1 and evolutionary mismatch

Scott reframes the entire GLP-1 drug conversation from mere vanity weight-loss into a profound societal correction of evolutionary biological impulses that fail in an era of industrial abundance.

The host holds their own ▶ 26:40 Sam details real-world semaglutide protocols

Sam counters high-level pharmaceutical theory with detailed first-hand domain expertise regarding syringe volume scaling, titration pacing, and direct physiological side effects.

the scores for every segment, with the reasoning behind each
ChapterTopicThe hosts as informed peerGuest teachingGuest disagreementThe hosts pushing backWhy
Opening Compliments and Persona Comparison 1210 Sam opens the show with flattering comparisons and praise for Scott's personal brand and writing style. Scott graciously accepts the compliments and shares early career anecdotes on developing resilience through failure.
Financial Anxiety and the Landmark L2 Exit 2511 Shaan asks Scott about reaching financial security, prompting Scott to explain his persistent financial anxiety and the mechanics of the $158M L2 acquisition. Scott educates the hosts on how compounding capital generates greater wealth than operational businesses.
Commercial Break: HubSpot CRM Platform 3321 Following a brief commercial break, Scott turns the spotlight back onto Sam, demanding to hear his exact exit numbers. Sam admits to walking away with $20M while still battling financial neurosis.
Wealth Defense, Living Below Means, and Neurosis 3634 Shaan pushes Scott on whether feeling broke with over a hundred million dollars is genuine neurosis or calculated virtue-signaling. Scott defends his anxiety as an authentic driver that enforces strict capital preservation discipline.
The Stabilizing Power of Recurring Cash Flow 3721 Scott lays out detailed strategic playbooks for 25-year-olds, contrasting seller-financed acquisitions of boomer service businesses for non-credentialed youth against corporate platform careers for elite graduates.
Disrupting Healthcare Through Artificial Intelligence 4645 Sam pushes back against Scott's recommendation of healthcare AI startups by highlighting regulatory capture and insurance friction. Scott counters forcefully, framing US healthcare as an unsustainable multi-trillion-dollar carcass ripe for disruption.
The Revolutionary Impact of GLP-1 Weight Loss Drugs 3731 Scott argues that GLP-1 weight loss drugs will have a larger economic impact than generative AI by scaffolding human evolutionary biology against hyper-palatable industrial foods.
First-Hand GLP-1 Experiences and Treatment Dynamics 5522 Sam shares specific domain knowledge from personal semaglutide usage regarding titration schedules, costs, and muscle loss side effects. Scott expands the discussion into broader macroeconomic impacts on hospital networks and pharmaceutical stocks.
Pharmacy Realities, Accutane, and Self-Deprecation 2312 After bantering about public pharmacy announcements, Scott shares a personal story about how Accutane cured his severe adolescent acne and transformed his confidence. The hosts lightly rib Scott about his humblebrag problems.
The Inverse Galloway Index and Online Retaliation 4564 Sam cites the Inverse Galloway Index showing tech companies Scott bet against beating the market by 61%. Scott mounts a spirited defense, calling out cherry-picked data windows and online bot campaigns funded by crypto and VC detractors.
Information Warfare and Digital Disinformation 3466 Sam directly challenges Scott on whether foreign bot farms are targeting him or if he is overestimating his significance to geopolitical actors. Scott insists that high-profile commentators are obvious targets for asymmetric disinformation campaigns.
Public Fame vs. The Ideal of Being Rich and Anonymous 2511 Scott reflects on the validation of public notoriety versus the ideal of remaining rich and anonymous. He then reveals the rigorous analytical preparation and humor design behind his six-figure keynote speaking engagements.

Statements from this episode (26)

Insight
Galloway: America does not embrace failure, it merely tolerates it
“We don't embrace failure, that's bullshit, but we tolerate it.”
Scott Galloway Oct 24, 2023 ▶ 3:51
Disclosure
Galloway: RedEnvelope collapse wiped out my wealth in 11 days
“And my stock went from seven bucks this year to zero in about 11 days. And when the company had declared chapter 11 and I lost, you know, I lost pretty much everything.”
Scott Galloway Oct 24, 2023 ▶ 5:12
Insight
Galloway: Wealthy elites promote silence on money to hide tax advantages
“Not talking about money is basically a decorum that is promoted by the incumbents and the wealthy, such that you don't understand how much money wealthy people have to keep poor and middle class people under the illusion that, oh, you should be paying 45% taxe…”
Scott Galloway Oct 24, 2023 ▶ 5:43
Disclosure
Galloway committed to giving away 100% of his current income
“Five years ago, I decided I was going to give away every dollar I made in current income.”
Scott Galloway Oct 24, 2023 ▶ 6:26
Assertion Supported
Galloway: L2 sold for $158M with insiders owning roughly 70%
“No, it sold for a hundred and fifty eight million, but we'd only done one round of venture capital. So the. You know, the common shareholders, you know, I was the largest equity owner. So the top, you know, between me and the top six employees, we probably own…”
Scott Galloway Oct 24, 2023 ▶ 7:36
Assertion Not checkable as stated
Galloway has made more money investing than from running businesses
“I've made more money investing, actually, than I've made for my small, for my businesses”
Scott Galloway Oct 24, 2023 ▶ 8:08
Disclosure
Sam Parr walked away with $20M from his company sale
“At the end of the process, I walked away with about twenty million dollars.”
Sam Parr Oct 24, 2023 ▶ 9:26
Disclosure
Parr: My portfolio is 80/20 index funds plus HubSpot and Airbnb
“And then I own HubSpot stock still, and then I own Airbnb stock. That's basically, basically my portfolio.”
Sam Parr Oct 24, 2023 ▶ 10:08
Disclosure
Galloway: Reinvesting all capital into new startups after early wins was a mistake
“And the mistake I made at your age when I had Some wins was I would double down and I would start another company and put all my money into one thing.”
Scott Galloway Oct 24, 2023 ▶ 12:11
Insight
Galloway: Wealthy individuals should sell concentrated single stocks and buy index funds
“Like you're, quite frankly, you should be selling down your Airbnb and your HubSpot stock and just letting, you don't need the needle in a haystack. You just need to buy the whole haystack because you've got enough capital.”
Scott Galloway Oct 24, 2023 ▶ 12:19
Insight
Galloway: Generating active income forces people to understand market value
“Being subject to trying to make as much money as you spend, or ideally more at any age, keeps you in the market. You have to understand what the market values and doesn't value.”
Scott Galloway Oct 24, 2023 ▶ 15:26
Insight
Galloway: Boomer-owned small businesses are desperate for transition liquidity events
“I think there are going to be a lot of businesses, whether it's carpet cleaning or gas stations or you know, hanging and selling draperies into small furniture companies that are owned by boomers. They're going to need a transition, nice small businesses, and …”
Scott Galloway Oct 24, 2023 ▶ 17:58
Insight
Galloway: Getting rich slowly at monopolies like Google is vastly underrated
“Going to work for a big company is vastly underrated. They can abuse their monopoly position. They will have that mole removed. You will get rich slowly working at Google or at McKinsey. So if you're credentialed you know, we over romanticize entrepreneurship.…”
Scott Galloway Oct 24, 2023 ▶ 19:26
Opinion
Galloway: US Healthcare Is the Most Disruptable Business in the World
“The most disruptable business in the world is US healthcare, three and a half to four trillion dollars.”
Scott Galloway Oct 24, 2023 ▶ 20:02
Disclosure
Galloway: I Wrote Down My 98point6 Investment and Lost Money
“And by the way, that, that investment I've written down by. It's been really hard. I've lost money so far on that.”
Scott Galloway Oct 24, 2023 ▶ 21:29
Prediction Not checkable as stated
Galloway: GLP-1 weight-loss drugs are a bigger deal than GPT-4
“I think GLP-I is bigger than GPT-IV.”
Scott Galloway Oct 24, 2023 ▶ 23:01
Assertion Supported
Galloway: People on Ozempic drink 60% less alcohol
“They're finding out people on Ozempic drink 60% less alcohol.”
Scott Galloway Oct 24, 2023 ▶ 25:46
Assertion Contradicted
Parr: Most GLP-1 users pay $500 to $1,000 monthly out of pocket
“Most people using it now are just paying 500 to a thousand dollars a month.”
Sam Parr Oct 24, 2023 ▶ 26:49
Prediction Not checkable as stated
Galloway: GLP-1 adoption could put entire hospital networks out of business
“Hospital networks, entire hospital networks could go out of business if they're really honest.”
Scott Galloway Oct 24, 2023 ▶ 30:00
Opinion
Galloway: We hit 'peak AI' for investors around September 2023
“I think AI, we've kind of hit peak AI. I love it. I use it a lot, but it's a little bit overhyped right now. We're definitely kind of, I would say, I think about a month ago we hit peak AI in terms of, from an investor standpoint, I would not want to be buying…”
Scott Galloway Oct 24, 2023 ▶ 30:36
Opinion
Galloway: Wealthy people losing 10 pounds drive GLP-1 sales over the obese
“Who GOP-I should be who it should reach right now is poor and middle-income households that are obese. That's where the greatest societal benefit would be right now. Who I think is probably driving the sales are rich people who want to lose the last 10 or 20 p…”
Scott Galloway Oct 24, 2023 ▶ 31:50
Insight
Galloway: VCs launch smear campaigns against critics threatening their profits
“I would say don't never get in between a venture capitalist and their second million, because they will take to Twitter and call you a plagiarist or accuse you of having done terrible things at NYU, which you've never Ever been accused of, much less people hav…”
Scott Galloway Oct 24, 2023 ▶ 38:00
Disclosure
Galloway: Investigators tied my Twitter trolls to criticized companies' shareholders
“I hired a firm to unmask some of the people who were attacking me, it was clearly like the same language, and like, they're using fake accounts, and it was almost always someone who had a large financial position, and the company that I said was overvalued.”
Scott Galloway Oct 24, 2023 ▶ 39:06
Insight
Galloway: A reliable algorithm for happiness is being rich and anonymous
“I do think there is an algorithm for happiness, though, a pretty good one, and that is to be rich but anonymous, because at some point I'm going to become the villain.”
Scott Galloway Oct 24, 2023 ▶ 44:24
Disclosure
Galloway averages $112,000 per speaking gig across 30 accepted talks
“Speaking is the most lucrative business I've ever been, and I had 340 inbound requests for speaking. I accepted 30 of them. I averaged a 112,000 dollars for speaking engagement.”
Scott Galloway Oct 24, 2023 ▶ 45:50
Disclosure
Mastercard paid Galloway $150,000 for a one-hour speech in Barcelona
“MasterCard and they're spending me a hundred, you know, they're spending a 150,000 bucks to have me speak for an hour in Barcelona, which I did last week”
Scott Galloway Oct 24, 2023 ▶ 46:57
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 300 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.